Stay Updated
Press Releases
Drug Corporations Ring in July with New Price Hikes
WASHINGTON, D.C. — July brought warm weather and new price hikes for Americans already struggling under unfair list prices. Pfizer announced price increases on 100 drugs, a move that comes as Americans continue to identify rising drug costs as a top priority for Congress. But Pfizer officials weren’t alone in thinking they could get away […]
Press Releases
Patient Group to House Democrats: Don’t Cut Bad Deal with Big Pharma
WASHINGTON, D.C. — “Don’t Get Fooled Again.” That’s the message from cancer patient and founder and president of Patients For Affordable Drugs David Mitchell to 50 Democratic members of the House. The members all signed on to a letter supporting drug corporations’ lobbying efforts to rollback Big Pharma’s contribution to Medicare that saves patients and taxpayers money. […]
Press Releases
Big Pharma's list prices are crushing America's seniors
WASHINGTON, DC — Seniors are filling fewer prescriptions for brand-named drugs, but they’re spending significantly more because list prices keep going up, according to a new government report. In response, David Mitchell, a cancer patient and founder of Patients For Affordable Drugs, issued the following statement: “Today’s report from the HHS Inspector General makes it […]
Press Releases
St. Louis — Patients For Affordable Drugs stood with Lora Moser, a cystic fibrosis patient unable to afford the medicines her family spent decades fundraising to develop, and launched a new campaign demanding that Vertex Pharmaceuticals lower the price of its life-extending drugs. Moser and Patients For Affordable Drugs were represented Thursday at a meeting of […]
Press Releases
Patients For Affordable Drugs Delivers Petition to AbbVie Calling for End to Biosimilar Delay Deals
WASHINGTON, DC — Patients For Affordable Drugs sent a petition with more than 1,000 signatures demanding pharmaceutical giant AbbVie stop delaying the introduction of biosimilar alternatives to Humira, a move that hurts patients by keeping prices high. The company announced in April it had inked a deal with manufacturer Samsung Bioepis that would guarantee AbbVie market exclusivity on Humira — the […]
Press Releases
The Good, The Missing, and The Ugly: The Drug Price Proposals Announced by the Trump Administration
WASHINGTON, DC — President Trump today gave a highly-anticipated speech on his Administration’s plans to lower drug prices. He railed against high prices and a rigged system, and we appreciate that he brought the rhetorical heat. But we must judge this set of proposals based on the substance and the standard the president set himself […]
Press Releases
ALERT: PhRMA Spends Record $$$ Lobbying
WASHINGTON, DC — Patients For Affordable Drugs’ Executive Director, Ben Wakana, issued the following statement regarding the news that PhRMA, the pharmaceutical industry’s main trade organization, broke a record for money spent lobbying in the first quarter of 2018. “Drug corporations are running scared. The public knows the truth about America’s rigged prescription drug pricing system, so PhRMA is […]
Press Releases
Patient Group Calls For Investigation Into AbbVie’s abusive Pay-for-Delay deals
WASHINGTON, D.C. — Patients For Affordable Drugs (P4AD) called on the Federal Trade Commission to investigate a pay-for-delay deal cut by the pharmaceutical giant AbbVie. In a letter to Congress and the Federal Trade Commission, the patient group asked the FTC to investigate whether AbbVie’s recent deal with Samsung Bioepis is anti-competitive and violates antitrust laws. […]